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Abstract
Background: Recent developments in sequence databases provide the opportunity to relate the
expression pattern of genes to their genomic position, thus creating a transcriptome map.
Quantitative trait loci (QTL) are phenotypically-defined chromosomal regions that contribute to
allelically variant biological traits, and by overlaying QTL on the transcriptome, the search for
candidate genes becomes extremely focused.
Results: We used our novel data mining tool, ExQuest, to select genes within known diabesity
QTL showing enriched expression in primary diabesity affected tissues. We then quantified
transcripts in adipose, pancreas, and liver tissue from Tally Ho mice, a multigenic model for Type
II diabetes (T2D), and from diabesity-resistant C57BL/6J controls. Analysis of the resulting
quantitative PCR data using the Global Pattern Recognition analytical algorithm identified a number
of genes whose expression is altered, and thus are novel candidates for diabesity QTL and/or
pathways associated with diabesity.
Conclusion:  Transcription-based data mining of genes in QTL-limited intervals followed by
efficient quantitative PCR methods is an effective strategy for identifying genes that may contribute
to complex pathophysiological processes.
Background
Understanding the molecular etiology of disease proc-
esses is a pressing goal of 21st century medicine. Comple-
tion of the mouse genome holds considerable promise in
the discovery of genes responsible for genetically deter-
mined complex diseases. Quantitative trait loci (QTL) are
allelically variant regions detected by virtue of their con-
tribution to the overall complex disease phenotype and
thus are "experiments in nature", which mark chromo-
somal intervals carrying genes with a proven disease
involvement. Since gene expression is a key link between
the genome and the plethora of phenotypic traits exhib-
ited, tools that permit the analysis of the tissue expression
pattern of genes in their chromosomal context provides a
bridge between QTL and the genes responsible.
Global microarray gene expression technologies offer a
promising, unbiased approach toward this goal in that
they reveal gene expression changes, which can be corre-
lated with the disease phenotype. However, such global
methods of analysis are not routine analytical tools and
can suffer from incomplete gene coverage, as well as lack
of sensitivity. Because only a small fraction of the tran-
scriptome is typically involved in any given
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etiopathological process, bioinformatic data mining tools
that allow for the intelligent prioritization of genes would
make it possible to employ more routine and sensitive
expression technologies, such as quantitative polymerase
chain reaction (QPCR). ExQuest [1,2] organizes pre-exist-
ing information-rich expression databases in a way that
quantitative tissue and/or developmental gene expression
patterns can be extracted and displayed within the context
of whole chromosomes. By overlaying ExQuest "chromo-
somal expression maps" with QTL coordinates, one can
search within defined genomic intervals for candidate
genes with enhanced expression in tissues consistent with
disease pathology. Screening candidates by QPCR will
determine whether or not they exhibit expression changes
in genetically resistant versus susceptible mice.
Type II diabetes (T2D), also referred to as non-insulin
dependent diabetes mellitus, is characterized by insulin
resistance of target cells combined with insufficient insu-
lin production and/or abnormal secretion by pancreatic
β -cells, which eventually results in chronically elevated
glucose levels in the circulation. Obesity is a major risk
factor for T2D, and the term "diabesity" has been coined
to collectively describe these overlapping conditions [3].
This paper describes an ExQuest compilation of novel
candidate genes from mouse diabesity QTL intervals
mapped to chromosomes 1, 4, 10, 17, 19 and X. This is
followed by QPCR analysis of the ExQuest candidates, in
addition to known diabetes and metabolism genes
selected from the literature, using tissues derived from the
newly defined T2D model, Tally Ho (TH) [4]. By selecting
genes from QTL intervals derived from multiple diabesity
models and using the TH mouse as a susceptible strain to
test for differential expression, we have identified a
number of genes whose altered expression may be
involved in the development of diabesity.
Results
Diabesity-relevant candidate gene selection
To identify candidate genes that contribute to diabesity,
we first established the local boundaries of 29 QTL from
the LocusLink database that contribute to body weight,
adiposity or T2D, and map to mouse chromosomes 1, 4,
10,17, 19 and X (Table 1). Using ExQuest, we were able to
cluster publicly available ESTs to genomic fragments,
extract and normalize tissue information from EST
datasheet records, and display quantitative expression
information linearly along the six chromosomes for over
70 tissues. We then narrowed the chromosomal search by
overlaying the in silico expression data with QTL intervals.
We were particularly interested in genes with known or
potential metabolic function whose expression patterns
Table 1: Genes selected for expression analysis by ExQuest.
Chr QTL1 Genes picked via ExQuest Total Genes in 
Region
Interval Range 
(Mb)
1 Obq2 Gsta3 73 13.7
Obq7, Wt6q1, Insq2, Insq6 Aox1, Fn1, Pecr, Igfbp2, Plcd4, Scg2, IRS-1, Inpp5d 401 44.1
Nidd6 Qscn6 85 9.4
Obq9 Fmo1, Fmo3, Apoa2 117 11.7
Wt6q2 Hsd11b1 63 7.3
4 Bwq1 Decr1 64 12.1
Triglq1, Bglq4 Ttpa, Bhmt, Baat, Aldo2 40 9.8
Nidd1, Dob1 Lepr, Dio1, Scp2, Faah, Usp1 350 32.4
Tafat Ela3b, Ela2, Dvl1 319 18.0
10 Insq9, Igfbp3q2 Ass1, Ftcd, Col18a1, Itgb2, Agpat3, Ndufs7, Oaz1, Pah, Igf-1, Nr1h4, Kitl 605 55.1
Bgeq8 Rdh7, Hsd17b9 257 19.8
17 Obq4, Wta4 Plg, Acat2, Actl, Hagh, Igfals, Decr2, Clps, Tff1, Tff2, Tff3, Apom 554 27.2
Hdl4 Gnmt, Lrg, Sepr 161 10.7
Insq5 Abcg5 69 10.0
19 Iba4 Aldh1a1, Aldh1a7, Vldlr, Plce1 190 23.3
Afw8 Pi4k2a, Cpn1, Elovl3 159 8.8
Nobq2, Bglq13 Ins1, Gpam, Facl5 39 8.4
Tanidd1, T2dm2 Gfra1, Pnlip, Pnliprp1, Pnliprp2 40 3.6
X Bw1 Rgn 149 51.5
Bw3 Rab9 278 30.0
1QTL name, abbreviation: Obesity, Obq; Body weight, 6 weeks, Wt6q; Insulin, Insq; Non-insulin-dependent diabetes mellitus, Nidd; Body weight, Bwq; 
Triglyceride, Triglq; Body growth late, Blgq; Dietary obesity, Dob; Tally ho associated mesenteric fat pad weight, Tafat; Insulin-like growth factor 
binding protein 3, Igfbp3q; Body growth early, Bgeq; Weight adult, Wta; High density lipoprotein level, Hdl; Induction of brown adipocytes, Iba; 
Abdominal fat weight, Afw; New Zealand obese, Nobq; Tally ho associated non-insulin dependent diabetes mellitus, Tannid; Type 2 diabetes mellitus, 
T2dm; Body weight, Bw.BMC Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2156/6/12
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were biased towards high expression in three diabesity rel-
evant-tissues, pancreas, liver and adipose tissue, for which
there was good EST library representation. (Skeletal mus-
cle was not included due to the lack of available mouse
EST libraries.) An example is illustrated in Figure 1A, in
which a region of genes with expression strongly biased
toward pancreatic tissue is found centered over the 1-LOD
95% confidence interval of the TH QTL Tafat [4]. By using
ExQuest's zoom-in capability, resolution down to the
expression of individual exons revealed that the expres-
sion bias was explained by a single gene, Elastase 2 (Ela2),
with a pattern of expression that includes pancreas, stom-
ach and tongue (Fig. 1B). A second example is illustrated
in Figure 1C, in which a cluster of pancreatic expressing
genes is localized to two chromosome 19 T2D QTL,
T2dm2 [5] and Tanidd1 [4]. The expanded chromosomal
view revealed that this cluster contained pancreatic lipase
(Pnlip) and two paralogs, Pnliprp1 and Pnliprp2. From all
QTL intervals, we chose the 71 "best expression" candi-
dates (Table 1) out of a possible 4,013 genes as predicted
by Ensembl's gene annotation. From PubMed searches,
we selected an additional 24 genes considered to be
highly relevant to diabesity and/or metabolism, as well as
the standard normalizer 18S RNA, bringing our total to
96, a convenient number for QPCR profiling (for gene list
and oligonucleotide primer sequences, see Additional file
1).
Real-time QPCR profiling
The newly-described TH T2D mouse model develops
obesity, hyperinsulinemia, hyperlipidemia, and male-
limited hyperglycemia [4]. To test the validity of our can-
didate gene selection and determine a quantitative molec-
ular signature for this mouse model, we extracted adipose,
liver and pancreas RNA from three early diabetic (as veri-
fied by glycemic index) 7-week-old male TH mice, as well
as three age and sex matched B6 controls. Real-time QPCR
was then independently performed for all 96 genes on the
three biological replicates, and the results were processed
using GPR software (for raw Ct values and GPR Reports,
see Additional files 2, 3 and 4). Twenty-one of 96 genes
exhibited significant expression changes between TH and
control B6 mouse tissues (Table 2). Fifteen were among
the 71 candidates chosen by ExQuest, while six were from
the 24-gene PubMed pool (Table 3).
Novel genes potentially implicated in the progression or 
response to diabetes
To assess the novelty of the differentially expressed
ExQuest-selected genes in regard to diabesity, we per-
formed an extensive PubMed search for articles associated
with both the gene name (or its alternative nomenclature
as defined by LocusLink gene name aliases), and diabetes
or obesity. The number of articles retrieved were typically
one to two orders of magnitude lower for the differentially
expressed ExQuest selected genes in comparison to the
genes analyzed with known diabesity or metabolism
involvement, with many having no literature citations
(Table 3). QTL-based ExQuest expression mining thus
revealed a number of novel diabesity candidate genes
with little to no prior association with this disease.
Discussion
Our results suggest that in silico data mining focused on
gene expression in diabesity-affected tissues and limited
to intervals containing diabesity-specific QTL (and thus
enriched in genes that contribute to diabesity) is an effi-
cient method to identify genes whose expression is altered
in T2D-susceptible mice. This analysis not only demon-
strated expression alterations in genes known to be asso-
ciated with the development of diabesity, but also
identified a number of novel genes whose expression
changes may contribute to the development of diabesity.
Expression changes in genes mapping within TH QTL
could be considered as candidates for transcriptional pol-
ymorphisms contributing to the associated TH QTL. How-
ever, genes selected on the basis of other diabesity QTL
that showed transcriptional differences in the TH/B6 com-
parison are more likely minor QTL in the TH model or
symptomatic effects of diabesity rather than a major
genetic cause of the TH disease.
As other diabesity studies commonly observe, there were
highly significant changes in adipose tissue expression of
Pparg and Lep. This included a ~5-fold increase in leptin
expression in TH adipose with no accompanying increase
in expression of the leptin receptor (Lepr). Since leptin is
responsible for the regulation of food intake [6], this
increase is most likely in response to incipient weight
gain. In contrast, the observed decrease in the expression
of peroxisome proliferator activated receptor gamma
(Pparg), both in TH adipose tissue and liver, is consistent
with a decrease in adipocyte differentiation often
observed in obese states [7,8]. In addition, Pparg agonists
are generally associated with promoting insulin sensitiza-
tion in the context of obesity [9].
Other genes previously associated with diabesity and
showing differential expression in TH vs. B6 tissues
included a 28.1-fold decrease of glucose transporter 2
(Glut2) in adipose, a 2.9-fold decrease in 1-acylglycerol-3-
phosphate O-acyltransferase 2 (Agpat2) in adipose, and a
1.2-fold decrease in lipoprotein lipase (Lpl) in liver. Their
reduced expression in the TH model might be in response
to disease onset.
Serum albumin levels are decreased in T2D patients
(reviewed in [10]). The primary source of serum albumin
is liver. Albumin synthesis is decreased in both diabetic
humans and in rat T2D models[11,12] and in liver cellsBMC Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2156/6/12
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Mirrored tissue-specific expression (red) and absolute EST representation (green) for whole ExQuest chromosomes Figure 1
Mirrored tissue-specific expression (red) and absolute EST representation (green) for whole ExQuest chromosomes. Maxi-
mum scales set for specific or absolute expression is within the circle at the centromere. (a) Pancreas expression for mouse 
chromosome 10 showing peak position of the LOD for the QTL Tafat over a pancreas expression peak that contains the gene 
Ela2. (b) Quantitative tissue specific expression profile for the gene Ela2. Results are derived from the number of Ela2-aligned 
EST hits normalized for library density. (c) Pancreas expression for mouse chromosome 19. Genes in the Tinidd1 and T2dm2 
region are pancreas specific (red) and highly expressed (green). Arrow shows a 20X zoom of 3 individual genes Pnlip 
(1810018F18Rik), Pnliprp1 and Pnliprp2, which contribute to the large pancreatic histogram peak.
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deprived of insulin [13]. We failed to detect any alteration
in the normally high levels of Alb1 expression in liver, but
TH mice showed a 9.4-fold decrease in Alb1 expression in
adipose tissue. Whether this fat-specific decrease in Alb1
expression is an early manifestation of subsequent
hypoalbuminemia remains to be established.
Altered expression of a number of ExQuest-selected genes
was also found. TH livers showed a 15.6-fold expression
increase compared with B6 for the very low-density lipo-
protein receptor (Vldlr). As a deficiency in Vldlr has been
reported to reduce adipocyte size and obesity in the ob/ob
mouse model [14], this expression alteration may contrib-
ute to TH diabesity. The expression of hydroxysteroid
(17β ) dehydrogenase 9 (Hsd17b9), which localizes to the
early body weight QTL Bgeq8 QTL, was elevated 9.5-fold
in TH livers. While the function of this gene is not
described in the literature, its paralog 11beta-hydroxyster-
oid dehydrogenase type 1 (Hsd11b1) bidirectionally cata-
lyzes the conversion of cortisol to the inactive metabolite
cortisone. Over 150 articles describe an association of
Hsd11β 1 with diabesity, and an intronic Hsd11b1 poly-
morphism is associated with obesity and insulin resist-
ance in children [15]. However, whether the elevated
expression of the Hsd17b9 paralog in TH liver is a candi-
date for Bgeq8 remains to be established.
Exocrine secretion of pancreatic lipases are known to
hydrolyze triglycerides to free fatty acids in the small intes-
tine. Pancreatic lipase (Pnlip) and two paralogs, Pnliprp1
and  Pnliprp2, were expressed preferentially in pancreas
and mapped very close to the peak of the LOD values for
the overlapping diabesity QTL, T2dm2 and Tannidd1 (Fig.
1b). T2dm2 and Tannidd1 are responsible for increased
insulin levels [5] and elevated plasma glucose [4], respec-
tively. Long-term high fat feeding, leading to glucose
intolerance, occurs with a simultaneous decrease in
mRNA expression of Pnlip [16]. While no expression alter-
ation in the normally high levels of expression of Pnlip or
its closely related Pnliprp1 paralog were found, Pnliprp2
expression was decreased 21.8-fold in TH pancreas when
mice were fed a 4% fat diet. By facilitating fat storage, the
consequence of which is hyperglycemic diabetes, the
selective decrease in Pnliprp2  in TH mice may explain
Tanidd1, and potentially, the genetically overlapping
T2dm2 QTL.
Trefoil 3 (Tff3), which maps to the Obq4 obesity QTL, was
the most significantly changed of all genes analyzed. It is
quite transcriptionally active in control B6 liver but virtu-
ally undetectable in TH liver. Trefoils are small, stable
secretory proteins expressed in goblet cells in the gastroin-
testinal mucosa where they stabilize the mucus layer and
promote epithelial healing [17]. Mice deficient in Tff3 are
highly susceptible to colon damage [18], which is not
commonly associated with T2D. While the colon is the
primary tissue of expression, Tff3 has also been reported
to be expressed in the bile ducts of normal human liver
and is upregulated in diseased livers [19]. However, a
potential association of the remarkable reduction of Tff3
expression in TH liver with diabesity remains to be
established.
While not detectably expressed in the liver or fat tissue in
B6 or TH mice, Ela2 was ranked by GPR as the gene most
significantly changed in the pancreas, with a 55-fold
reduction in TH vs. B6 mRNA (Table 2). Originally cloned
from the pancreas [20], Ela2 is located within 75 kb of the
peak LOD score for the TH QTL Tafat. ExQuest expression
profiling suggests that Ela2 expression is biased strongly
towards digestive tissues (pancreas, stomach and tongue)
of normal mice (Fig. 1A). Both whole pancreas and Islet
Table 2: GPR report of B6 vs. TH gene expression comparisons.1
Gene # Total hits2 GPR Score3 Fold change4
Adipose
Pparg 44 0.92 -14.9
Lep 40 0.83 5.3
Alb1 39 0.81 -9.4
Gsta3 38 0.79 -10.6
Glut2 37 0.77 -28.1
Fmo1 35 0.73 -4.8
Scp2 25 0.52 -2.4
Agpat2 24 0.50 -2.9
Agpat3 19 0.40 -2.1
Pancreas
Ela2 39 0.95 -55.8
Pnliprp2 39 0.95 -21.8
Kitl 29 0.71 -4.3
Col18a1 18 0.44 -1.7
Ela3b 16 0.40 -1.8
Liver
Tff3 63 1.00 -593.0
Vldlr 58 0.92 15.6
Hsd17b9 57 0.91 9.5
Pparg 56 0.89 -11.5
Igfbp2 46 0.73 -2.7
Kitl 39 0.62 -2.4
Decr2 28 0.44 -1.3
Lpl 25 0.40 -1.2
Pi4k2a 25 0.40 -1.1
1 Complete GPR report and raw CT data in Supplementary Data.
2Number of qualified normalizer genes against which test gene ∆ CT 
values are statistically significant at p = 0.05.
3 # of total hits / # of qualified normalizers. A GPR score = 0.40, 
meaning that the test gene ∆ CT comparisons differed at p= 0.05 
compared with at least 40% of the qualified normalizers, is considered 
most reliable.
4Relative to 18S RNA.BMC Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2156/6/12
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of Langerhans EST libraries show high levels of Ela2
expression, suggesting that the endocrine pancreas
actively transcribes it. Ela2 (alias polymorphonuclear neu-
trophil elastase) encodes a serine protease present in neu-
trophil endosomal granules, which are known to be
important in myelopoiesis (reviewed in [21]). The sub-
stantially decreased expression in TH pancreas may result
in secretory granules deficient in this serine protease.
Conclusion
We have tested the concept that transcription-based
ExQuest data mining of genes in QTL-limited intervals is
an effective method to identify genes that contribute to
the complex genetic disease, diabesity. By limiting the in
silico candidate genes to those with expression biased to
tissues normally affected by this disease, we have shown
that sensitive, high-throughput QPCR methods reveal
expression changes in novel genes in the TH model. The
search within additional diabesity QTL using this tech-
nique may facilitate the identification of a limited number
of genes that comprise a 'complete' diabesity molecular
phenotype. Moreover, this general approach may be an
efficient method to identify genes that contribute to com-
plex pathophysiological processes.
Table 3: Medline citations to genes showing altered expression in TH mice.
Gene name Diabesity-relevant articles General function
Genes chosen known to be involved in diabetes with expression change
Alb1 5548 Lipid binding and carrier activity
Leptin 3170 Hormone activity
Lpl 775 Lipid catabolism or fatty acid metabolism
Pparg 702 Lipid metabolism and steroid hormone receptor activity
Glut2 142 Glucose transport and carbohydrate metabolism
Agpat2 5 Phospholipid biosynthesis
ExQuest chosen genes with expression change, known or unknown to be involved in diabetes
Col18a11 7 Potent antiangiogenic protein, structural molecule
Vldlr2 7 Lipid transport
Scp2 4 Sterol carrier activity, lipid binding, and steroid biosynthesis
Fmo1 3 Electron transport and oxidoreductase activity
Pnliprp2 1 Lipid catabolism
KitL 0 Signal transduction
Igfbp2 0 Insulin-like growth factor binding
Ela2 0 Proteolysis and peptidolysis
Ela3b 0 Proteolysis and peptidolysis, and cholesterol metabolism
Gsta3 0 Biosynthesis of steroid hormones
Agpat3 0 Phospholipid metabolism
Hsd17b9 0 Steriod biosynthesis and oxidoreductase activity
Decr2 0 Peroxisome organization and biogenesis, and oxidoreductase activity
Tff3 0 Epithelium healing
Pi4k2a 0 Inositol/phosphatidlinositol kinase activity
Functional summary of genes with expression changes3
Lipid related gene activity 8
Hormone related gene activity 6
Inflammation or response to 
injury
4
Oxidoreductase activity 3
Signal transduction 3
Proteolysis and peptidolysis 2
Carbohydrate related gene 
activity
1
1Hsd17b9 medline search: there are 88 articles for the homolog "11-beta hydroxysteroid dehydrogenase", and 157 with "hydroxysteroid 
dehydrogenase".
2 Vldlr MEDLINE search: 4818 diabesity relevant articles found for Vldl.
3 Genes with dual functions are counted twice.BMC Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2156/6/12
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Methods
QTL analysis
Obesity and T2D QTL on mouse chromosomes
1,4,10,17,19, and X, were identified by a LocusLink search
[22]. Information regarding individual QTL boundaries
was gathered through the Mouse Genome Informatics site
(MGI) [23]. Simple sequence length polymorphism
(SSLP) markers extracted from MGI were queried at the
Ensembl website [24] to determine the exact chromo-
somal location.
In silico expression analysis
ExQuest [1,2] is a gene expression program that uses pub-
lic EST databases to create a comprehensive transcriptome
map overlaid with tissue specific expression. In brief,
chromosomal sequence was downloaded from Ensembl
and stringently masked using the RepeatMasker program.
ESTs were clustered to the chromosomes using the MegaB-
last algorithm on a 32-node, 64 cpu Beowulf cluster. Tis-
sue or library source information was extracted from EST
datasheet records for each 10,000 base pair genomic frag-
ment and normalized based upon library density and EST
hit frequency. Whole chromosomal plots display total
EST hits for each tissue as well as normalized data, which
is a measure of a specific tissue expression level compared
to all other tissues available in dbEST. In this way, the
expressional bias of a genomic region towards a specific
tissue is determined. QTL intervals were overlaid onto the
chromosomal plots displaying adipose, liver and pancreas
expression and these regions were then scanned for areas
that exhibited high tissue specificity. ESTs clustering to
genomic regions showing high tissue specificity were
linked to Unigene [25], to determine if the particular EST
aligned to a known gene cluster from which mRNA
sequence could be extracted for primer design.
Tissue procurement, RNA preparation and cDNA synthesis
Three 7 week old, male TH mice (nonfasting blood glu-
cose levels 295 to 433 mg/dl) and their respective T2D-
resistant, sex- and age-matched C57BL/6J (B6) controls,
were maintained on a 4% fat diet [4]. Following CO2
asphyxiation, pancreas, adipose, and liver tissues were
collected. Each biological replicate sample was processed
in parallel. Whole pancreas tissue was collected, placed in
3.5 mL lysis/binding solution from the RNAqueous®-
4PCR Kit (Ambion # 1914), homogenized and stored in
an ethanol/dry ice bath until the RNA could be extracted.
Approximately 25 mg of adipose and liver tissue were col-
lected and stored in 1 mL of RNALater (Ambion # 7020)
until RNA was extracted.
For pancreatic RNA extraction, we prepared a 5.7 M CsCl
solution containing 0.05 M EDTA, pH 7.0. The solution
was made RNase free using RNASecure (Ambion # 7005),
conforming to manufacturer's recommendations. 5.0 mL
SW 55.1 ultracentrifuge tubes were made RNase free by
treatment with RNAZap (Ambion # 9780) for five min-
utes followed by washing with Nuclease-Free water
(Ambion # 9932). 2.0 mL of the 5.7 M CsCl solution was
added to each tube. 3.0 mL of pancreatic solution was lay-
ered carefully on top. The tubes were centrifuged at
36,000RPM for 16–20 hours at 25°C in a SW 55.1 rotor.
The supernatant was carefully removed 1.0 mL at a time,
using fresh pipette tips. When approximately 1.0 mL
remained, the tubes were quickly inverted and dried with
filter paper to prevent residual RNases from contact with
the RNA pellet at the bottom of the tube. The RNA was
resuspended in 2 portions of 150 µL of RNA resuspension
solution (Ambion #7010), conforming to manufacturer's
recommendations.
Adipose and liver tissues stored in RNAlater were proc-
essed using the RNAqueous®-4PCR Kit, conforming to the
manufacturer's recommendations.
All RNA was subsequently digested with DNAse in accord-
ance with the aforementioned protocol and analyzed for
purity using the Agilent Bioanalyzer 2100. RNA concen-
trations were determined using a NanoDrop® ND-1000
Spectrophotometer. The collected RNA was converted
into cDNA via MessageSensor™ RT Kit (Ambion # 1745),
conforming to manufacturer's recommendations. The
adipose tissue cDNA reaction synthesis contained 350 ng
of RNA while pancreas and liver samples utilized 1000 ng
of RNA. All RNA was stored at -80°C when it was not
being processed.
Primer design
Sequences for the candidate genes were extracted from
GenBank and imported into Primer Express software v2.0
from Applied Biosystems, Inc (ABI). All primers were pre-
pared in accordance with universal thermocycling param-
eters as described for real-time PCR on the ABI 7900HT.
The primer sequences were then blasted [26] to ensure
specificity of the primers. Forward and reverse primers
(MWG Biotech) were combined in a 96-well master plate
at a final concentration of 50 µM. Short amplicons of
approximately 75 bp were generated to ensure a high level
of sensitivity. Dissociation curves confirmed that only sin-
gle amplicons were generated. Amplicons were TA cloned
(Invitrogen # K204040) and bidirectionally sequenced to
confirm sequence identity for instances in which genes
exhibited significant expression. For gene names and
primer sequences, see Additional file 1.
Real-Time QPCR
Each reaction consisted of 5.0 µl of 2X SYBR Green Master
Mix (ABI # 4309155), 3.0 µL of dH2O, 1.5 µL of 0.5 µM
forward and reverse primer solution, and 0.5 µL of cDNA.
Pancreas and liver cDNA was diluted 1:10 before additionBMC Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2156/6/12
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to the master-mix, while adipose cDNA was diluted 1:3. A
384-well plate format was utilized such that 4 samples ×
96 genes were amplified per plate. The plate was sealed
with Optical Adhesive Covers (ABI # 4311971) and cen-
trifuged. The samples were assayed on the ABI Prism
7900HT Signal Detection System v2.0 using default con-
ditions, and baseline range values were set from 3 to 10
cycles.
The data were then analyzed using Global Pattern Recog-
nition (GPR) analytical software [27,28]. In typical QPCR
experiments, the comparative expression of all genes is
based on single gene normalizer, whose expression is
assumed to be invariant. In contrast, the Global Pattern
Recognition (GPR) algorithm employs a global normali-
zation feature in which the expression data from each
gene are normalized against that of every other gene, thus
eliminating the reliance on single gene normalization.
GPR's ranking is based on biological replicate consistency,
and is thus not skewed by fold change in the magnitude
of expression. For raw CT values and GPR Reports, see
Additional files 2, 3 and 4.
Abbreviations used in this paper
QPCR, quantitative polymerase chain reaction; QTL,
quantitative trait loci; GPR, global pattern recognition;
ExQuest, expressional quantification of ESTs
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